Fact CheckerSign in

NCT07437716Completed

Impact Of Laparoscopic Sleeve Gastrectomy On Obesity-Related Comorbidities In Patients Over 65 Years

Impact Of Laparoscopic Sleeve Gastrectomy On Obesity-Related Comorbidities In Patients Over 65 Years: A Prospective Comparative Study

Source: ClinicalTrials.gov · Last updated 27 Feb 2026

Brief summary (registry, in English)

This study compares laparoscopic sleeve gastrectomy (a type of weight-loss surgery) with non-surgical care in adults aged 65 or older who have severe obesity and related health problems like type 2 diabetes, high blood pressure, knee joint issues from osteoarthritis, or sleep apnea. Over 12 months, 60 patients chose either surgery or diet counseling with medications for their conditions (30 in each group). The main goals are to measure improvements in these health issues, weight loss, and safety. Why This Study Matters Severe obesity in older adults raises risks for serious health conditions that diet and medications often fail to fix long-term. Surgery like sleeve gastrectomy removes part of the stomach to limit food intake and improve hormones that control hunger and blood sugar, but its benefits need direct proof against usual care in seniors. What Happens in the Study Patients picked their treatment: surgery group got the procedure plus routine care; non-surgery group got nutrition advice and standard drugs. Doctors tracked weight, blood tests, blood pressure, sleep studies, knee X-rays, drug needs, and side effects at 1, 3, 6, and 12 months.

Status (registry)
Completed
Study type
Interventional
Enrollment
60 (actual)
First submitted
18 Feb 2026
Start date
1 Jan 2023
Primary completion date
1 Mar 2025
Lead sponsor
Kafrelsheikh University
NCT number
NCT07437716

What you commit to

  • Study type: Interventional
  • Participants enrolled: 60
  • From 1 Jan 2023 to the primary completion date, 1 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous abdominal surgery

Other illness

  • Severe cardiopulmonary disease preventing surgery or follow-up
  • Active malignancy
  • Uncontrolled psychiatric illness

Other

  • Inability to comply with follow-up visits

Who the study is looking for

  • Age ≥65 years
  • Body Mass Index (BMI) ≥40 kg/m²
  • Presence of at least one weight-related comorbidity: type 2 diabetes mellitus (T2D), hypertension (HTN), obstructive sleep apnea (OSA), or osteoarthritis (OA)
  • Ability to provide informed consent and complete 12-month follow-up protocol

Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Kafrelsheikh University
Coordinator of this site? Confirm its status
Kafr ash ShaykhEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.